デフォルト表紙
市場調査レポート
商品コード
1301128

ペンニードルの市場規模、シェア、動向分析レポート:製品別、針の長さ別、治療法別、地域別、セグメント予測:2023年~2030年

Pen Needles Market Size, Share & Trends Analysis Report By Product (Standard & Safety Pen Needles), By Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), By Therapy (Insulin, Glucagon-like-Peptide-1), Region And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 105 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
ペンニードルの市場規模、シェア、動向分析レポート:製品別、針の長さ別、治療法別、地域別、セグメント予測:2023年~2030年
出版日: 2023年06月23日
発行: Grand View Research
ページ情報: 英文 105 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ペンニードル市場の成長と動向

GrandView Research, Inc.の最新レポートによると、世界のペンニードル市場規模は2030年までに77億米ドルに達し、CAGR 11.8%で拡大すると予測されています。

糖尿病の有病率の上昇が、ペンニードル市場の大幅な成長の主な理由です。国立医学図書館によると、糖尿病患者数は2023年に151万人増加すると予想されており、これは主に人口の高齢化に起因しています。このような世界中の糖尿病の高い有病率は、ペンニードルの需要の上昇につながっています。糖尿病を患う患者は、簡単にドラッグデリバリーを行うことができるペン型注射器を使用するのが一般的です。

さらに、肥満は糖尿病の重大な原因です。肥満の人は2型糖尿病を患っていることが多く、ターゲット市場にとって最も収益貢献度の高い人の1人となっています。したがって、2型糖尿病患者は、ペン型注射針を製造する企業にとって共通のターゲット人口です。

技術的進歩の高まりもまた、市場の成長を促進すると予想されます。ペン型注射針は、快適で簡単なインスリン送達モードを可能にします。これらのデバイスは技術的に高度であり、注射器やバイアルと比較して優れた代替ドラッグデリバリー方法を提供します。例えば、Becton, Dickinson, and Company社は、BD Ultra-Fine Nano 4mm Pen Needles with Easy Flow Technologyを発売しました。

ペンニードル市場レポートハイライト

  • 安全針と比較して費用対効果の高い針が入手可能なため、標準針が2022年の市場を独占
  • セーフティペンニードルは、継続的な技術進歩により予測期間中に有利な成長を示すと予測される
  • 針の長さでは、8mmが2022年に最大のシェアを占める。これは、この針が糖尿病患者に提供する利便性に起因する
  • 針長4mmは、その短さにより予測期間中に魅力的なCAGRを示すと期待される
  • 糖尿病患者の間でインスリンの自己投与に関する意識が高まっているため、2022年にはインスリン療法が最大の市場シェアを占める
  • 2022年のペン型注射針市場は欧州が支配的で、欧州地域の糖尿病有病率の高さから北米がこれに続く
  • アジア太平洋地域は、簡単なドラッグデリバリーに関する糖尿病患者の意識レベルの上昇により、予測期間中に最も高い成長率を示すと予測される

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 調査手法
  • 情報調達
  • 情報またはデータ分析
  • 市場の形成と検証
  • モデル詳細
  • 二次情報のリスト
  • 一次情報のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場スナップショット
  • セグメントのスナップショット
  • 競合のスナップショット

第3章 ペンニードル市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/アンシラリー市場見通し
  • 普及と成長の見通しマッピング
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ペンニードル市場分析ツール
    • 業界分析- ポーターの分析
    • PESTEL分析
    • 主要取引と戦略的提携の分析
    • 市場参入戦略

第4章 ペンニードル市場:製品推定・動向分析

  • 定義と範囲
  • 製品市場シェア、2022年および2030年
  • セグメントダッシュボード
  • 製品別の世界のペンニードル市場の見通し
  • 以下の市場規模、予測および動向分析、2018年から2030年まで
    • 標準ペンニードル
    • セーフティペンニードル

第5章 ペンニードル市場:ニードルの長さ推定・動向分析

  • 定義と範囲
  • 針の長さの市場シェア、2022年と2030年
  • セグメントダッシュボード
  • 針の長さ別のペンニードル市場の見通し
  • 以下の市場規模、予測および動向分析、2018年から2030年まで
    • 4mm
    • 5mm
    • 6mm
    • 8mm
    • 10mm
    • 12mm

第6章 ペンニードル市場:治療推定・動向分析

  • 定義と範囲
  • 治療市場シェア、2022年と2030年
  • セグメントダッシュボード
  • 治療別のペンニードル市場の見通し
  • 以下の市場規模、予測および動向分析、2018年から2030年まで
    • インスリン
    • GLP-1
    • 成長ホルモン

第7章 ペンニードル市場:地域推定・動向分析

  • 地域市場シェア分析、2022年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 地域市場シェアと主要企業、2022年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • 市場用途、予測および動向分析、2018年から2030年:
  • 北米
    • 市場推計・予測、2018~2030年(収益)
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • インド
    • 中国
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • イノベーター
  • ベンダー情勢
    • 主なディストリビューターとチャネルパートナーのリスト
    • 主な顧客
    • 主要企業の市場シェア分析、2022
    • Novo Nordisk A/S
    • Becton
    • Dickinson and Company
    • TERUMO CORPORATION
    • Owen Mumford Ltd.
    • Ypsomed
    • B. Braun Melsungen AG
    • HTL-STREFA
    • UltiMed, Inc.
    • Allison Medical, Inc.
    • Artsana SPa
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America Pen needles market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 5 North America Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 6 U.S. Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 8 U.S. Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 9 Canada Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 11 Canada Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 12 Europe Pen needles market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 15 Europe Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 16 U.K. Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 17 U.K. Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 18 U.K. Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 19 Germany Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 21 Germany Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 22 France Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 23 France Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 24 France Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 25 Italy Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 27 Italy Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 28 Spain Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 30 Spain Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 31 Denmark Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 33 Denmark Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 34 Sweden Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 36 Sweden Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 37 Norway Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 39 Norway Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Pen needles market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 44 Japan Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 46 Japan Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 47 China Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 48 China Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 49 China Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 50 India Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 51 India Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 52 India Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 53 Australia Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 54 Australia Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 55 Australia Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 56 Thailand Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 57 Thailand Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 58 Thailand Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 59 South Korea Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Korea Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 61 South Korea Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 62 Latin America Pen needles market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 64 Latin America Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 65 Latin America Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 66 Brazil Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 68 Brazil Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 69 Mexico Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 71 Mexico Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 72 Argentina Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 74 Argentina Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa Pen needles market, by region, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 79 South Africa Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 81 South Africa Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 85 UAE Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 87 UAE Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Pen needles market, by therapy, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Pen needles market: market outlook
  • Fig. 14 Pen needles market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Pen needles market driver impact
  • Fig. 20 Pen needles market restraint impact
  • Fig. 21 Pen needles market strategic initiatives analysis
  • Fig. 22 Pen needles market: product movement analysis
  • Fig. 23 Pen needles market: product outlook and key takeaways
  • Fig. 24 Standard pen needles market estimates and forecast, 2018 - 2030
  • Fig. 25 Safety pen needles therapy market estimates and forecast, 2018 - 2030
  • Fig. 26 Pen needles market: needle length movement analysis
  • Fig. 27 Pen needles market: needle length outlook and key takeaways
  • Fig. 28 4mm market estimates and forecast, 2018 - 2030
  • Fig. 29 5mm market estimates and forecast, 2018 - 2030
  • Fig. 30 6mm market estimates and forecast, 2018 - 2030
  • Fig. 31 8mm market estimates and forecast, 2018 - 2030
  • Fig. 32 10mm market estimates and forecast, 2018 - 2030
  • Fig. 33 12mm market estimates and forecast, 2018 - 2030
  • Fig. 34 Pen needles market: therapy movement analysis
  • Fig. 35 Pen needles market: therapy outlook and key takeaways
  • Fig. 36 Insulin market estimates and forecast, 2018 - 2030
  • Fig. 37 Glucagon-like-peptide-1 market estimates and forecast, 2018 - 2030
  • Fig. 38 Glucagon-like-peptide-1 market estimates and forecast, 2018 - 2030
  • Fig. 39 Global Pen needles market: Regional movement analysis
  • Fig. 40 Global Pen needles market: Regional outlook and key takeaways
  • Fig. 41 Global market shares and leading players
  • Fig. 42 North America market share and leading players
  • Fig. 43 Europe market share and leading players
  • Fig. 44 Asia Pacific market share and leading players
  • Fig. 45 Latin America market share and leading players
  • Fig. 46 Middle East & Africa market share and leading players
  • Fig. 47 North America: SWOT
  • Fig. 48 Europe SWOT
  • Fig. 49 Asia Pacific SWOT
  • Fig. 50 Latin America SWOT
  • Fig. 51 MEA SWOT
  • Fig. 52 North America, by country
  • Fig. 53 North America
  • Fig. 54 North America market estimates and forecast, 2018 - 2030
  • Fig. 55 U.S.
  • Fig. 56 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 57 Canada
  • Fig. 58 Canada market estimates and forecast, 2018 - 2030
  • Fig. 59 Europe
  • Fig. 60 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 61 U.K.
  • Fig. 62 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 63 Germany
  • Fig. 64 Germany market estimates and forecast, 2018 - 2030
  • Fig. 65 France
  • Fig. 66 France market estimates and forecast, 2018 - 2030
  • Fig. 67 Italy
  • Fig. 68 Italy market estimates and forecast, 2018 - 2030
  • Fig. 69 Spain
  • Fig. 70 Spain market estimates and forecast, 2018 - 2030
  • Fig. 71 Denmark
  • Fig. 72 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 73 Sweden
  • Fig. 74 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 75 Norway
  • Fig. 76 Norway market estimates and forecast, 2018 - 2030
  • Fig. 77 Asia Pacific
  • Fig. 78 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 79 Japan
  • Fig. 80 Japan market estimates and forecast, 2018 - 2030
  • Fig. 81 China
  • Fig. 82 China market estimates and forecast, 2018 - 2030
  • Fig. 83 India
  • Fig. 84 India market estimates and forecast, 2018 - 2030
  • Fig. 85 Australia
  • Fig. 86 Australia market estimates and forecast, 2018 - 2030
  • Fig. 87 Thailand
  • Fig. 88 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 89 South Korea
  • Fig. 90 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 91 Latin America
  • Fig. 92 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 93 Brazil
  • Fig. 94 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 95 Mexico
  • Fig. 96 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 97 Argentina
  • Fig. 98 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 99 Middle East and Africa
  • Fig. 100 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 101 Saudi Arabia
  • Fig. 102 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 103 South Africa
  • Fig. 104 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 105 UAE
  • Fig. 106 UAE market estimates and forecast, 2018 - 2030
  • Fig. 107 Kuwait
  • Fig. 108 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 109 Participant categorization- Pen needles market
  • Fig. 110 Market share of key market players- Pen needles market
目次
Product Code: GVR-1-68038-427-7

Pen Needles Market Growth & Trends

The global pen needles market size is expected to reach a value of USD 7.7 billion by 2030, expanding at a CAGR of 11.8%, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of the pen needles market. According to the National Library of Medicine, the number of people with diabetes is expected to climb by 1.51 million in 2023, owing primarily to the ageing population. Such high prevalence of diabetes across the globe has led to rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which help in easy drug delivery.

In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors to the target market. Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles.

Rising technological advancements is also expected to drive the market growth. Pen needles allow comfort and easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, Becton, Dickinson, and Company launched BD Ultra-Fine Nano 4mm Pen Needles with Easy Flow Technology, which will enable diabetic patients with easy adherence to insulin therapy regimens.

Pen Needles Market Report Highlights

  • Standard needles dominated the market in 2022 due to the availability of cost-effective needles as compared to safety needles
  • Safety pen needles are anticipated to showcase lucrative growth over the forecast period due to the continuous technological advancements
  • Amongst the needle lengths, 8mm held the largest share in 2022. This is due to the convenience offered by this needle type on diabetic patients
  • Needle length of 4mm are expected to witness attractive CAGR over the forecast period owing to its short length
  • Insulin therapy accounted for the largest market share in 2022 due to rising awareness regarding self-administration of insulin amongst the diabetic patients
  • Europe dominated the pen needles market in 2022 followed by North America owing to the high prevalence of diabetes in the European region
  • Asia Pacific region is anticipated to exhibit the highest growth rate over the forecast period owing to the rising awareness levels amongst the diabetic population regarding easy drug delivery
  • Some of the key players include Becton, Dickinson and Company, B. Braun Melsungen AG, Novo Nordisk A/S, Owen Mumford, Ltd., Ypsomed, HTL-STREFA, and TERUMO CORPORATION.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Needle Length
    • 1.1.3. Therapy
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Snapshot

Chapter 3. Pen Needles Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Growing prevalence of diabetes
      • 3.4.1.2. Technological advancements
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Preference for alternative drug delivery method
      • 3.4.2.2. Lack of skilled professionals
  • 3.5. Pen Needles Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Pen Needles Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Standard Pen Needles
    • 4.1.2. Safety Pen Needles
  • 4.2. Product Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Pen Needles Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Standard Pen Needles
      • 4.5.1.1. Standard pen needles market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Safety Pen Needles
      • 4.5.2.1. Safety pen needles market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Pen Needles Market: Needle Length Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. 4mm
    • 5.1.2. 5mm
    • 5.1.3. 6mm
    • 5.1.4. 8mm
    • 5.1.5. 10mm
    • 5.1.6. 12mm
  • 5.2. Needle Length Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Pen Needles Market by Needle Length Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. 4mm
      • 5.5.1.1. 4mm market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. 5mm
      • 5.5.2.1. 5mm market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. 6mm
      • 5.5.3.1. 6mm market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. 8mm
      • 5.5.4.1. 8mm market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.5. 10mm
      • 5.5.5.1. 10mm market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.6. 12mm
      • 5.5.6.1. 12mm market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Pen Needles Market: Therapy Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Insulin
    • 6.1.2. Glucagon-like-peptide-1
    • 6.1.3. Growth Harmone
  • 6.2. Therapy Market Share, 2022 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Pen Needles Market by Therapy Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Insulin
      • 6.5.1.1. Insulin market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Glucagon-like-peptide-1
      • 6.5.2.1. Glucagon-like-peptide-1 market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Growth Harmone
      • 6.5.3.1. Growth harmone market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Pen Needles Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2022 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2022
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
  • 7.6. North America
    • 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 7.6.3. Canada
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 7.7. Europe
    • 7.7.1. UK
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive Scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement scenario
      • 7.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 7.7.2. Germany
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 7.7.3. France
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 7.7.4. Italy
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 7.7.5. Spain
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 7.7.6. Denmark
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 7.7.7. Sweden
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 7.7.8. Norway
      • 7.7.8.1. Key country dynamics
      • 7.7.8.2. Competitive Scenario
      • 7.7.8.3. Regulatory framework
      • 7.7.8.4. Reimbursement scenario
      • 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 7.8. Asia Pacific
    • 7.8.1. Japan
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive Scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement scenario
      • 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 7.8.2. India
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 7.8.3. China
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 7.8.4. South Korea
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 7.8.5. Australia
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 7.8.6. Thailand
      • 7.8.6.1. Key country dynamics
      • 7.8.6.2. Competitive Scenario
      • 7.8.6.3. Regulatory framework
      • 7.8.6.4. Reimbursement scenario
      • 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 7.9. Latin America
    • 7.9.1. Brazil
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive Scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement scenario
      • 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 7.9.2. Mexico
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 7.9.3. Argentina
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 7.10. MEA
    • 7.10.1. South Africa
      • 7.10.1.1. Key country dynamics
      • 7.10.1.2. Competitive Scenario
      • 7.10.1.3. Regulatory framework
      • 7.10.1.4. Reimbursement scenario
      • 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 7.10.2. Saudi Arabia
      • 7.10.2.1. Key country dynamics
      • 7.10.2.2. Competitive Scenario
      • 7.10.2.3. Regulatory framework
      • 7.10.2.4. Reimbursement scenario
      • 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 7.10.3. UAE
      • 7.10.3.1. Key country dynamics
      • 7.10.3.2. Competitive Scenario
      • 7.10.3.3. Regulatory framework
      • 7.10.3.4. Reimbursement scenario
      • 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 7.10.4. Kuwait
      • 7.10.4.1. Key country dynamics
      • 7.10.4.2. Competitive Scenario
      • 7.10.4.3. Regulatory framework
      • 7.10.4.4. Reimbursement scenario
      • 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2022
    • 8.3.4. Novo Nordisk A/S
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Becton
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Dickinson and Company
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. TERUMO CORPORATION
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Owen Mumford Ltd.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Ypsomed
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. B. Braun Melsungen AG
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. HTL-STREFA
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. UltiMed, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Allison Medical, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Artsana S.P.a
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiative